Unlicensed Medicines – Global Access
Article
13 Dec 2016
Accessing Medicines that aren’t available in South Africa
Clinigen Consulting
Insight Blog
01 Dec 2016
21st Century Cures Act – are you ready?
Clinigen Commercial Medicines
Article
29 Nov 2016
Prevention of Toxicities by Cytoprotection: The Role of Amifostine in the Supportive Care of Cancer for Patients with...
Unlicensed Medicines – Managed Access
Article
17 Nov 2016
An exciting outlook for pre-approval access and compassionate use.
Clinigen Consulting
Insight Blog
16 Nov 2016
An ethical compassionate use policy is only possible if your internal access policy is robust.
Clinical Trial Services
Video
19 Oct 2016
Clinigen CTS - What Makes Our Service Different?
Clinical Trial Services
Video
19 Oct 2016
Clinigen CTS – Direct to Site Supply Chain Service
Clinigen Group
Insight Blog
05 Oct 2016
Insights on Access: A welcome from Chief Medical Officer, Ivo Timmermans
Unlicensed Medicines – Managed Access
White Paper
03 Oct 2016
White Paper on Real-World Data Collection within the MAP Setting
Unlicensed Medicines – Managed Access
Article
03 Oct 2016
Market Access Insight: Early Patient Access